Atypical antipsychotic in the adolescent: What are the implications for the future?;Les antipsychotiques atypiques chez l'adolescent: Quels enjeux pour l'avenir?

Encephale

Volumn 37, Issue 4 SUPPL. 4, 2011, Pages 15-17

  Cohen, D ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT;

ADOLESCENT; ARTICLE; HUMAN;

ADOLESCENT; ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; FRANCE; HUMANS; MALE; MOVEMENT DISORDERS; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 82155188968     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0013-7006(11)70028-8     Document Type: Article

References (8)

1. E. Acquaviva, S. Legleye, and G.R. Auleley Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data BMC Psychiatry 9 2009 72
2. Bonnot O, Holzer L. Les antipsychotiques de seconds generations chez l'enfant et l'adolescent. Neuropsychiatrie de l'Enfance et de l'Adolescence ( paraitre).
3. O. Bonnot, R. Inaoui, and C. Lloret Linares Principe de surveillance des effets métaboliques, de l'hyperprolactinémie et du rythme cardiaque pour les antipsychotiques atypiques chez l'enfant et l'adolescent Neuropsychiatr Enfance Adolesc 58 2010 431 438
4. F. Charfi, D. Cohen, and Houeto Jl Tardive dystonia induced by atypical neuroleptics: a case report with olanzapine. Journal of Child and Adolescent Psychopharmacology 14 2004 151 154
5. Cohen D, Bonnot O, Bodeau N, et al. Adverse effects of second generation antipsychotics in children and adolescents: a bayesian meta-analysis (soumis publication).
6. Governale L, Mehta H. Outpatient use of atypical antipsychotic agents in the pediatric population: years 2004-2008-2009; http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/ UCM193204.pdf. Accessed 07/26, 2010.
7. C. Sevilla-Dedieu, and V. Kovess-Masféty Psychotropic medication use in children and adolescents: a study from France J Child Adolesc Psychopharmacol 18 2008 281 289
8. S.W. Woods, A. Martin, and S.G. Spector Effects of development on olanzapine-associated adverse events J Am Acad Child Adolesc Psychiatry 41 2002 1439 1446 (Pubitemid 44698520)